+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Bioengineered Skin Substitutes Market: Focus on Product Type, Application, End User, 4 Regional Data, 12 Countries' Data, Competitive Landscape, Regulatory Scenario, Analysis and Forecast, 2020-2030

  • ID: 5211801
  • Report
  • December 2020
  • Region: Global
  • 210 Pages
  • BIS Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
Global Bioengineered Skin Substitutes Market to Reach $4.33 Billion by 2030

FEATURED COMPANIES

  • AbbVie Inc.
  • ACell, Inc.
  • AlloSource
  • Anika Therapeutics, Inc.
  • Aroa Biosurgery Limited
  • Cook Biotech Incorporated
  • MORE

Market Report Coverage - Bioengineered Skin Substitutes

Market Segmentation

  • By Product: Allogenic, Autologous, Xenogeneic, Acellular, and Others
  • By Application: Chronic Wounds and Acute Wounds
  • By End User: Hospitals, Specialty Clinics, Wound Care Centers, and Others

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe
  • Asia-Pacific - China, Australia, Japan, India, South Korea, and Rest-of-Asia-Pacific
  • Rest-of-the-World

Growth Drivers

  • Increasing Prevalence of Diabetes and Diabetic Foot Ulcers
  • Rising Cases of Chronic Wounds and Burn Injuries
  • Increasing Funds/Aids by the Government for Research Purposes
  • Growing Prominence of Regenerative Medicine and Tissue Engineering Products
  • Increasing Obesity

Market Challenges

  • Biocompatibility Issues and Stringent Regulations
  • Limitations of Skin Substitutes
  • Expensive Treatment

Market Opportunities

  • Patient Awareness and Improved Lifestyle in Emerging Economics
  • Advancing Inclination Toward Acellular Skin Substitutes

Key Companies Profiled

Anika Therapeutics, Inc., AbbVie, Inc., Smith & Nephew plc, Integra LifeSciences Corporation, Boston Scientific Corporation, Organogenesis, Inc., Mölnlycke Health Care AB, Vericel Corporation, Stryker Corporation, Zimmer Biomet, and Aroa Biosurgery, Cook Biotech Incorporated, Promethean LifeSciences, Inc., XCELLentis NV, and AlloSource

Key Questions Answered in this Report:

  • What is the importance of bioengineered skin substitutes, and what is their origin? What are the different bioengineered skin substitutes products available in the market, and what are their benefits?
  • What are the major technological advancements witnessed by the global bioengineered skin substitutes market since 2015, and what is the future scope of the market? What are the current key trends of the global bioengineered skin substitutes market, and how is the market evolving?
  • What was the market size of the global bioengineered skin substitutes market in 2019, and what is the market size anticipated to be in 2030? What is the expected growth rate of the global bioengineered skin substitutes market during the period between 2020 and 2030?
  • What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What are the major drivers, challenges, and opportunities of the global bioengineered skin substitutes market?
  • What are the major key players of the global bioengineered skin substitutes market? How much market share did each of these players occupy in the market in 2019? Which companies are anticipated to be highly disruptive in the future, and why?
  • What is the regulatory scenario of the global bioengineered skin substitutes market? What are the initiatives implemented by different governmental bodies and guidelines put forward by them to regulate the commercialization of bioengineered skin substitutes products?
  • What is the supply chain associated with wound care, and what is the cost associated with it?
  • What are the key developmental strategies implemented by the key players of the global bioengineered skin substitutes market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the current revenue contribution of the global bioengineered skin substitutes market (by product type), and how is it expected to evolve in the forecast period?
  • What is the current revenue contribution of the global bioengineered skin substitutes market (by application type), and how is it expected to evolve in the forecast period?
  • What is the current revenue contribution of the global bioengineered skin substitutes market (by end user), and how is it expected to evolve in the forecast period?
  • Which region is expected to contribute the highest sales in the global bioengineered skin substitutes market during the period between 2019 and 2030? What are the leading countries of different regions that contribute significantly toward the growth of the global bioengineered skin substitutes market?

Market Overview

Technological advancements in wound biologics coupled with innovations in the field of tissue engineering have led to the development of advanced wound healing options and strategies, including bioengineered skin substitutes. These products are being designed to treat a wide range of acute and chronic wounds that pose a serious healthcare threat globally. According to a study published in the International Society for Pharmacoeconomics and Outcomes Research’s Value in Health Journal (January 2018), the economic costs associated with chronic wound management in the U.S. is pegged between $28.1 to $31.7 billion for 8.2 million affected patients. Hence, increasing incidence of chronic wounds, as well as rising cases of burns injuries, are actively promoting the growth of the global bioengineered skin substitutes market. Further, the factors contributing to the huge demand for skin substitutes are their emerging applications, superior property, and huge investment by government and federal agencies.

Healthcare experts have found the global bioengineered skin substitutes market as one of the markets with high attractiveness from the investors, promoting huge investment driving technological innovations. The purpose of this study is to gain a holistic view of the bioengineered skin substitutes market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products, applications, and end users associated with the global bioengineered skin substitutes market across different regions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global bioengineered skin substitutes market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

Within the research report, the market has been segmented into ‘products’, ‘applications’, ‘end-user’, and ‘regions’. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The bioengineered skin substitutes market is currently at a blooming phase, with the presence of various juggernauts such as AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering a wide range of bioengineered skin substitutes products in the market. Several companies are attempting to enter the market and sustain themselves in the competition by adopting different strategies varying from partnerships and collaborations to business expansions and product launches.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • ACell, Inc.
  • AlloSource
  • Anika Therapeutics, Inc.
  • Aroa Biosurgery Limited
  • Cook Biotech Incorporated
  • MORE

1 Product Definition
1.1 Inclusion and Exclusion

2 Scope of the Work
2.1 Overview: Report Scope
2.2 Segmentation of the Global Bioengineered Skin Substitutes Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period

3 Research Methodology
3.1 Overview: Report Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling

4 Market Overview
4.1 Introduction to Skin Substitutes
4.2 Bioengineered Skin Substitutes
4.3 History and Timeline of Tissue Engineering
4.4 Classification and Types of Skin Substitutes
4.5 Key Products Commercially Available in the Market
4.6 Future Trends and Developments
4.7 Addressable Market Size and Growth Potential, $Million, 2019-2030

5 Market Dynamics
5.1 Overview
5.2 Impact Analysis
5.3 Market Drivers
5.3.1 Increasing Prevalence of Diabetes and Diabetic Foot Ulcers
5.3.2 Rising Cases of Chronic Wounds and Burn Injuries
5.3.3 Increasing Funds/Aids by Governments for Research Purposes
5.3.4 Growing Prominence of Regenerative Medicines and Tissue-Engineering Products
5.3.5 Increasing Obesity
5.4 Market Restraints
5.4.1 Biocompatibility Issues and Stringent Regulations
5.4.2 Limitations of Skin Substitutes
5.4.3 Expensive Treatment
5.5 Market Opportunities
5.5.1 Patient Awareness and Improved Lifestyle in Emerging Economies
5.5.2 Advancing Inclination Toward Acellular Skin Substitutes

6 Industry Insights
6.1 Industry Evolution
6.2 Regulatory Framework Monitoring Skin Substitutes
6.2.1 Human-Derived Products Regulated Solely Under 21 CFR 1271 (HCT/Ps)
6.2.2 Human and Human/Animal-Derived Products Regulated Through the Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Process
6.2.3 Animal-Derived Products Regulated Under the 510(K) Process
6.2.4 Biosynthetic Products Regulated Under the 510(K) Process
6.3 Wound Management Cost
6.4 Supply Chain of Wound Care Products

7 Competitive Landscape
7.1 Overview
7.2 Key Developments and Strategies
7.2.1 M & A Activities
7.2.2 Partnerships and Alliances
7.2.3 Business Expansion
7.2.4 Others
7.3 Market Share Analysis
7.4 Growth Share Analysis (Opportunity Mapping)
7.4.1 By Product
7.4.2 By Application

8 Global Bioengineered Skin Substitutes Market (by Product)
8.1 Overview
8.2 Allogenic
8.3 Autologous
8.4 Xenogeneic
8.5 Acellular
8.6 Other Products

9 Global Bioengineered Skin Substitutes Market (by Application)
9.1 Overview
9.2 Chronic Wounds
9.2.1 Venous Leg Ulcers
9.2.2 Diabetic Foot Ulcers (DFU)
9.2.3 Pressure Ulcers (PUs)
9.2.4 Other Chronic Wounds
9.3 Acute Wounds
9.3.1 Surgical and Traumatic Wounds
9.3.2 Burn Injuries

10 Global Bioengineered Skin Substitutes Market (by End User)
10.1 Overview
10.2 Hospitals
10.3 Specialty Clinics
10.4 Wound Care Centers
10.5 Others

11 Global Bioengineered Skin Substitutes Market (by Region)
11.1 Overview
11.2 North America
11.2.1 Overview
11.2.2 U.S.
11.2.3 Canada
11.3 Europe
11.3.1 Overview
11.3.2 Germany
11.3.3 U.K.
11.3.4 France
11.3.5 Italy
11.3.6 Spain
11.3.7 Rest-of-Europe
11.4 Asia-Pacific
11.4.1 Overview
11.4.2 China
11.4.3 Japan
11.4.4 Australia
11.4.5 South Korea
11.4.6 India
11.4.7 Rest-of-Asia-Pacific
11.5 Rest-of-the-Word

12 Company Profiles
12.1 Overview
12.2 Boston Scientific Corporation
12.2.1 Company Overview
12.2.2 Role of Boston Scientific Corporation in the Global Bioengineered Skin Substitutes Market
12.2.3 Financials
12.2.4 Key Insights About Financial Health of the Company
12.2.5 SWOT Analysis
12.3 Smith & Nephew plc
12.3.1 Company Overview
12.3.2 Role of Smith & Nephew plc in the Global Bioengineered Skin Substitutes Market
12.3.3 Financials
12.3.4 Key Insights About Financial Health of the Company
12.3.5 SWOT Analysis
12.4 AbbVie Inc.
12.4.1 Company Overview
12.4.2 Role of AbbVie Inc. in the Global Bioengineered Skin Substitutes Market
12.4.3 Financials
12.4.4 Key Insights About Financial Health of the Company
12.4.5 SWOT Analysis
12.5 Stryker Corporation
12.5.1 Company Overview
12.5.2 Role of Stryker Corporation in the Global Bioengineered Skin Substitutes Market
12.5.3 Financials
12.5.4 SWOT Analysis
12.6 Anika Therapeutics, Inc.
12.6.1 Company Overview
12.6.2 Role of Anika Therapeutics, Inc. in the Global Bioengineered Skin Substitutes Market
12.6.3 Financials
12.6.4 Key Insights About Financial Health of the Company
12.6.5 SWOT Analysis
12.7 Zimmer Biomet Holdings, Inc.
12.7.1 Company Overview
12.7.2 Role of Zimmer Biomet Holdings, Inc. in the Global Bioengineered Skin Substitutes Market
12.7.3 Financials
12.7.4 Key Insights About Financial Health of the Company
12.7.5 SWOT Analysis
12.8 Vericel Corporation
12.8.1 Company Overview
12.8.2 Role of Vericel Corporation in Global Bioengineered Skin Substitutes Market
12.8.3 Financials
12.8.4 Key Insights About Financial Health of the Company
12.8.5 SWOT Analysis
12.9 Integra LifeSciences Corporation
12.9.1 Company Overview
12.9.2 Role of Integra LifeSciences Corporation in the Global Bioengineered Skin Substitutes Market
12.9.3 Financials
12.9.4 Key Insights About Financial Health of the Company
12.9.5 SWOT Analysis
12.1 Aroa Biosurgery Limited
12.10.1 Company Overview
12.10.2 Role of Aroa Biosurgery Limited in the Global Bioengineered Skin Substitutes Market
12.10.3 SWOT Analysis
12.11 Organogenesis Inc.
12.11.1 Company Overview
12.11.2 Role of Organogenesis Holdings Inc. in the Global Bioengineered Skin Substitutes Market
12.11.3 Financials
12.11.4 Key Insights About Financial Health of the Company
12.11.5 SWOT Analysis
12.12 Mölnlycke Health Care AB
12.12.1 Company Overview
12.12.2 Role of Mölnlycke Health Care AB in the Global Bioengineered Skin Substitutes Market
12.12.3 SWOT Analysis
12.13 AlloSource
12.13.1 Company Overview
12.13.2 Role of AlloSource in the Bioengineered Skin Substitutes Market
12.13.3 SWOT Analysis
12.14 Cook Biotech Incorporated
12.14.1 Company Overview
12.14.2 Role of Cook Biotech Incorporated in the Bioengineered Skin Substitutes Market
12.14.3 SWOT Analysis
12.15 Promethean LifeSciences, Inc.
12.15.1 Company Overview
12.15.2 Role of Promethean LifeSciences, Inc. in the Bioengineered Skin Substitutes Market
12.15.3 SWOT Analysis
12.16 ACell, Inc.
12.16.1 Company Overview
12.16.2 Role of ACell, Inc. in the Bioengineered Skin Substitutes Market
12.16.3 SWOT Analysis

List of Tables
Table 1: Leading Segments of the Global Bioengineered Skin Substitutes Market (by Revenue), 2019 and 2030
Table 4.1: Examples of Key Companies Offering Bioengineered Skin Substitutes
Table 5.1: Impact Analysis of Market Drivers
Table 5.2: Impact Analysis of Market Restraints
Table 5.3: Global Statistics of Diabetes and Diabetic Foot Ulcers
Table 5.4: Global Prevalence of Pressure Ulcer and Venous Leg Ulcer, 2018
Table 5.5: Examples of Acellular Skin Substitutes Offered by Key Companies
Table 6.1: Human-Derived Products Regulated Solely Under 21 CFR 1271 (HCT/Ps)
Table 6.2: Human and Human/Animal-Derived Products Regulated Through the Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Process
Table 6.3: Animal-Derived Products Regulated Under the 510(K) Process
Table 6.4: Biosynthetic Products Regulated Under the 510(K) Process
Table 7.1: M&A Activities (January 2017 and September 2020)
Table 7.2: Partnership and Alliances (January 2017 and September 2020)
Table 7.3: Business Expansions (January 2017 and September 2020)
Table 7.4: Other Key Developments (January 2017 and September 2020)
Table 8.1: Allogenic Products Offered by Key Companies
Table 8.2: Autologous Products Offered by Key Companies
Table 8.3: Xenogeneic Products Offered by Key Companies
Table 8.4: Acellular Products Offered by Key Companies
Table 9.1: Major Wound Types
Table 9.2: Global Venous Leg Ulcer Statistics
Table 9.3: Global Diabetic Foot Ulcer Statistics
Table 9.4: Global Pressure Ulcer Statistics

List of Figures
Figure 1: Global Bioengineered Skin Substitutes Market
Figure 2: Impact of Market Drivers and Market Restraints
Figure 3: Competitive Landscape (Key Developments: January 2017-September 2020)
Figure 4: Global Bioengineered Skin Substitutes Market Share (by Product), 2019 and 2030
Figure 5: Global Bioengineered Skin Substitutes Market Share (by Application), 2019 and 2030
Figure 6: Global Bioengineered Skin Substitutes Market Share (by End User), 2019 and 2030
Figure 7: Global Bioengineered Skin Substitutes Market Share (by Region), 2019 and 2030
Figure 2.1: Global Bioengineered Skin Substitutes Market Segmentation
Figure 3.1: Global Bioengineered Skin Substitutes Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Top-Down Approach (Segment-Wise Analysis)
Figure 3.4: Bottom-Up Approach (Segment-Wise Analysis)
Figure 4.1: Common Characteristics of Ideal Skin Substitutes
Figure 4.2: Timeline of Skin Tissue Engineering in Burn Surgery
Figure 4.3: Different Classification of Skin Substitutes
Figure 4.4: Future Trends and Developments in Bioengineering/Tissue Engineering Market
Figure 4.5: Global Bioengineered Skin Substitutes Market (by Value)
Figure 5.1: Market Dynamics
Figure 5.2: Major Limitations of Skin Substitutes
Figure 6.1: Industry Trends in Advanced Wound Care Market
Figure 6.1: Cost Breakup, Wound Management Life Cycle
Figure 7.1: Competitive Landscape (January 2017- April 2020)
Figure 7.2: Share of Key Developments and Strategies, January 2017-June 2020
Figure 7.3: Market Share Analysis of Global Bioengineered Skin Substitutes Market, 2019
Figure 7.4: Growth Share Matrix for Global Bioengineered Skin Substitutes Market (by Product), 2019-2030
Figure 7.5: Growth Share Matrix for Global Bioengineered Skin Substitutes Market (by Application), 2019-2030
Figure 8.1: Global Bioengineered Skin Substitutes Market Segmentation (by Product)
Figure 8.2: Global Bioengineered Skin Substitutes Market (by Product), 2019-2030
Figure 8.3: Global Bioengineered Skin Substitutes Market (Allogenic Products), 2019-2030
Figure 8.4: Global Bioengineered Skin Substitutes Market (Autologous Products), 2019-2030
Figure 8.5: Global Bioengineered Skin Substitutes Market (Xenogeneic Products), 2019-2030
Figure 8.6: Global Bioengineered Skin Substitutes Market (Acellular Products), 2019-2030
Figure 8.7: Global Bioengineered Skin Substitutes Market (Other Products), 2019-2030
Figure 9.1: Global Bioengineered Skin Substitutes Market Segmentation (by Application)
Figure 9.2: Global Bioengineered Skin Substitutes Market (by Application), 2019-2030
Figure 9.3: Global Bioengineered Skin Substitutes Market (by Chronic Wound), 2019-2030
Figure 9.4: Global Bioengineered Skin Substitutes Market (by Chronic Wound Disease Type), 2019-2030
Figure 9.5: Global Bioengineered Skin Substitutes Market (Venous Leg Ulcers), 2019-2030
Figure 9.6: Global Bioengineered Skin Substitutes Market (Diabetic Foot Ulcers), 2019-2030
Figure 9.7: Global Bioengineered Skin Substitutes Market (Pressure Ulcers), 2019-2030
Figure 9.8: Global Bioengineered Skin Substitutes Market (Other Chronic Wounds), 2019-2030
Figure 9.9: Global Bioengineered Skin Substitutes Market (by Acute Wound), 2019-2030
Figure 9.10: Global Bioengineered Skin Substitutes Market (by Acute Wound), 2019-2030
Figure 9.11: Global Bioengineered Skin Substitutes Market ( Surgical and Traumatic Wounds), 2019-2030
Figure 9.12: Global Bioengineered Skin Substitutes Market (Burn Injury), 2019-2030
Figure 10.1: Global Bioengineered Skin Substitutes Market Segmentation (by End User)
Figure 10.2: Global Bioengineered Skin Substitutes Market (by End User), 2019-2030
Figure 10.3: Global Bioengineered Skin Substitutes Market (Hospitals), 2019-2030
Figure 10.4: Global Bioengineered Skin Substitutes Market (Specialty Clinic), 2019-2030
Figure 10.5: Global Bioengineered Skin Substitutes Market (Wound Care Centers), 2019-2030
Figure 10.6: Global Bioengineered Skin Substitutes Market (Others), 2019-2030
Figure 11.1: Global Bioengineered Skin Substitutes Market (by Region), 2019 and 2030
Figure 11.2: Global Bioengineered Skin Substitutes Market (by Region), 2019-2030
Figure 11.3: North America: Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.4: North America: Market Dynamics
Figure 11.5: North America Bioengineered Skin Substitutes Market Share (by Country), 2019-2030
Figure 11.6: U.S. Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.7: Canada Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.8: Europe Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.9: Europe: Market Dynamics
Figure 11.10: Europe: Bioengineered Skin Substitutes Market Share (by Country), 2019-2030
Figure 11.11: Germany Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.12: U.K. Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.13: France: Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.14: Italy: Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.15: Spain: Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.16: Rest-of-Europe: Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.17: Asia-Pacific: Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.18: Asia-Pacific: Market Dynamics
Figure 11.19: Asia-Pacific: Bioengineered Skin Substitutes Market Share (by Country), 2019-2030
Figure 11.20: China Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.21: Japan Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.22: Australia Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.23: South Korea Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.24: India Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.25: Rest-of-Asia-Pacific Bioengineered Skin Substitutes Market, 2019-2030
Figure 11.26: Rest-of-the-World Bioengineered Skin Substitutes Market, 2019-2030
Figure 12.1: Shares of Key Company Profiles
Figure 12.2: Boston Scientific Corporation: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.3: Boston Scientific Corporation: Overall Financials, 2017-2019
Figure 12.4: Boston Scientific Corporation: Revenue (by Segment), 2017-2019
Figure 12.5: Boston Scientific Corporation: Revenue (by Region), 2017-2019
Figure 12.6: Boston Scientific Corporation: R&D Expenditure, 2017-2019
Figure 12.7: Boston Scientific Corporation: SWOT Analysis
Figure 12.8: Smith & Nephew plc: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.9: Smith & Nephew plc: Overall Financials, 2017-2019
Figure 12.10: Smith & Nephew plc: Revenue (by Segment), 2017-2019
Figure 12.11: Smith & Nephew plc: Revenue (by Region), 2017-2019
Figure 12.12: Smith & Nephew plc: R&D Expenditure, 2017-2019
Figure 12.13: Smith & Nephew plc: SWOT Analysis
Figure 12.14: AbbVie Inc.: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.15: AbbVie Inc.: Overall Financials, 2017-2019
Figure 12.16: AbbVie Inc.Revenue (by Region), 2017-2019
Figure 12.17: AbbVie Inc.: R&D Expenditure, 2017-2019
Figure 12.18: AbbVie Inc.: SWOT Analysis
Figure 12.19: Stryker Corporation: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.20: Stryker Corporation: Overall Financials, 2017-2019
Figure 12.21: Stryker Corporation: Revenue (by Segment), 2017-2019
Figure 12.22: Stryker Corporation: Revenue (by Region), 2017-2019
Figure 12.23: Stryker Corporation: SWOT Analysis
Figure 12.24: Anika Therapeutics, Inc.: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.25: Anika Therapeutics, Inc.: Overall Financials, 2017-2019
Figure 12.26: Anika Therapeutics, Inc.: Revenue (by Segment), 2017-2019
Figure 12.27: Anika Therapeutics, Inc.: Revenue (by Region), 2017-2019
Figure 12.28: Anika Therapeutics, Inc.: R&D Expenditure, 2017-2019
Figure12.29: Anika Therapeutics, Inc.: SWOT Analysis
Figure 12.30: Zimmer Biomet Holdings, Inc.: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.31: Zimmer Biomet Holdings, Inc.: Overall Financials, 2017-2019
Figure 12.32: Zimmer Biomet Holdings, Inc.: Revenue (by Segment), 2017-2019
Figure 12.33: Zimmer Biomet Holdings, Inc.: Revenue (by Region), 2017-2019
Figure 12.34: Zimmer Biomet Holdings, Inc.: R&D Expenditure, 2017-2019
Figure 12.35: Zimmer Biomet Holdings, Inc.: SWOT Analysis
Figure 12.36: Vericel Corporation: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12 37: Vericel Corporation: Overall Financials, 2017-2019
Figure 12.38: Vericel Corporation: Revenue (by Segment), 2017-2019
Figure 12.39: Vericel Corporation: R&D Expenditure, 2017-2019
Figure 12.40: Vericel Corporation: SWOT Analysis
Figure 12.41: Integra LifeSciences Corporation: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.42: Integra LifeSciences Corporation: Overall Financials, 2017-2019
Figure 12.43: Integra LifeSciences Corporation: Revenue (by Segment), 2017-2019
Figure 12.44: Integra LifeSciences Corporation: Revenue (by Region), 2017-2019
Figure 12.45: Integra LifeSciences Corporation: R&D Expenditure, 2017-2019
Figure 12.46: Integra LifeSciences Corporation: SWOT Analysis
Figure 12.47: Aroa Biosurgery Limited: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.48: Aroa Biosurgery Limited: SWOT Analysis
Figure 12.49: Organogenesis Holdings Inc.: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.50: Organogenesis Holdings Inc.: Overall Financials, 2017-2019
Figure 12.51: Organogenesis Holdings Inc.: Revenue (by Segment), 2017-2019
Figure 12.52: Organogenesis Holdings Inc.: R&D Expenditure, 2017-2019
Figure 12.53: Organogenesis Holdings Inc.: SWOT Analysis
Figure 12.54: Mölnlycke Health Care AB: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.55: Mölnlycke Health Care AB: SWOT Analysis
Figure 12.56: AlloSource: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.57: AlloSource: SWOT Analysis
Figure 12.58: Cook Biotech Incorporated: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.59: Cook Biotech Incorporated: SWOT Analysis
Figure 12.60: Promethean LifeSciences, Inc.: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.61: Promethean LifeSciences, Inc.: SWOT Analysis
Figure 12.62: ACell, Inc.: Product Portfolio for Global Bioengineered Skin Substitutes Market
Figure 12.63: ACell, Inc.: SWOT Analysis

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc.
  • ACell, Inc.
  • AlloSource
  • Anika Therapeutics, Inc.
  • Aroa Biosurgery Limited
  • Boston Scientific Corporation
  • Cook Biotech Incorporated
  • Integra LifeSciences Corporation
  • Mölnlycke Health Care AB
  • Organogenesis Inc.
  • Promethean LifeSciences, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll